» Articles » PMID: 20948917

Quality of Life of Long-term Survivors After a Distal Subtotal Gastrectomy

Overview
Specialty Oncology
Date 2010 Oct 16
PMID 20948917
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to investigate the impact of a distal subtotal gastrectomy on the quality of life (QoL).

Materials And Methods: The QoL data of 126 patients were obtained on their 5th annual follow-up visit after a curative distal subtotal gastrectomy for gastric cancer (Group A). The QoL data of 130 age- and gender-adjusted healthy population were obtained from the individuals who visited the health screening center for a medical check-up (Group B). There were 42 women and 84 men in the study group and their mean age was 56.0±11.1 years. QoL was assessed using the Korean versions of the European Organization for Research and Treatment of Cancer (EORTC) QoL Questionnaire Core 30 (QLQ-C30) and QLQ-STO22.

Results: The EORTC QLQ-C30 global health status and QoL scores of Group A and Group B were 63.9±22.7 and 61.3±22.1, respectively (p=0.361). Group A revealed a better score for emotional functioning (84.1±16.1 and 75.2±21.4, respectively; p<0.001), cognitive functioning (82.0±16.4 and 75.0±21.4, respectively; p=0.004) and fatigue (27.7±20.8 and 33.8±23.2, respectively; p=0.028). However, Group A revealed a worse score for nausea and vomiting (14.8±20.0 and 10.2±16.0, respectively; p=0.042), financial difficulties (14.8±22.9 and 7.1±16.1, respectively; p=0.002), reflux (16.7±17.7 and 10.1±17.0, respectively; p=0.003), eating restrictions (13.6±15.2 and 6.6±10.2, respectively; p<0.001) and body image (23.3±25.4 and 16.2±24.6, respectively; p=0.023).

Conclusion: The QoL of long-term survivors after a distal subtotal gastrectomy is still influenced by the surgery itself even though they are considered to be free of disease.

Citing Articles

Quality of Life of Young Gastric Cancer Survivors: An Interpretation in the Context of Our Society.

Lee S Medicina (Kaunas). 2024; 60(1).

PMID: 38276043 PMC: 10820035. DOI: 10.3390/medicina60010009.


Impact on quality of life with affirmative feedback on weight loss after gastrectomy.

Lee S, Chung H, Kwon O Sci Rep. 2023; 13(1):15454.

PMID: 37723236 PMC: 10507081. DOI: 10.1038/s41598-023-42695-w.


Surgery Matters: Progress in Surgical Management of Gastric Cancer.

Beyer K Curr Treat Options Oncol. 2023; 24(2):108-129.

PMID: 36656504 PMC: 9883345. DOI: 10.1007/s11864-022-01042-3.


Health-related quality of life after gastric cancer treatment in Brazil: Narrative review and reflections.

Pinheiro R, Mucci S, Zanatto R, Picanco Junior O, Oliveira A, Lopes Filho G World J Clin Cases. 2021; 9(17):4123-4132.

PMID: 34141775 PMC: 8173417. DOI: 10.12998/wjcc.v9.i17.4123.


Health-related quality of life after curative resection for gastric adenocarcinoma.

Grosek J, Zavrtanik H, Tomazic A World J Gastroenterol. 2021; 27(16):1816-1827.

PMID: 33967559 PMC: 8072188. DOI: 10.3748/wjg.v27.i16.1816.


References
1.
Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W . Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial. Lung Cancer. 2003; 43(1):83-91. DOI: 10.1016/s0169-5002(03)00280-0. View

2.
Tomita R, Tanjoh K, Fujisaki S . Novel operative technique for vagal nerve- and pyloric sphincter-preserving distal gastrectomy reconstructed by interposition of a 5 cm jejunal J pouch with a 3 cm jejunal conduit for early gastric cancer and postoperative quality of life 5 years.... World J Surg. 2004; 28(8):766-74. DOI: 10.1007/s00268-004-6987-2. View

3.
Tyrvainen T, Sand J, Sintonen H, Nordback I . Quality of life in the long-term survivors after total gastrectomy for gastric carcinoma. J Surg Oncol. 2008; 97(2):121-4. DOI: 10.1002/jso.20925. View

4.
Yun Y, Park Y, Lee E, Bang S, Heo D, Park S . Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004; 13(4):863-8. DOI: 10.1023/B:QURE.0000021692.81214.70. View

5.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View